Carcinogen-induced histone alteration in normal human mammary epithelial cells.
Little is known about early carcinogen-induced protein alterations in mammary epithelium. Detection of early alterations would enhance our understanding of early-stage carcinogenesis. Here, normal human mammary epithelial cells (HMECs) were exposed to dietary and environmental carcinogens [2-amino-1-methyl-6-phenylimidazo[4,5b]pyridine (PhIP), 4-aminobiphenyl (ABP), benzo[a]pyrene, 2,3,7,8-tetrachlorodibenzo-p-dioxin] individually or in combination. A phage display library of single-chain variable fragment antibodies was used to screen protein targets altered by the treatment. In combination with matrix-assisted laser desorption time of flight, we identified histone H3 as a target antigen. Although histone H3 total protein remained unchanged in control and treated HMEC, the methylation of lysine 4 was altered. A reduction in mono-methyl histone H3 (Lys 4) was observed in treated HMEC compared with control HMEC. This alteration was shown to be dependent on carcinogen concentration and specific for PhIP and ABP. To characterize potential histone demethylation mechanisms, localization and protein expression patterns of lysine-specific demethylase 1 (LSD1) were analyzed. In control HMEC, LSD1 was present at the nuclear periphery. However, following 72 h carcinogen treatment, LSD1 localized within the nucleus. Within 48 h after treatment, mono-methyl histone H3 (Lys 4) was restored and LSD1 localization was reversed. Protein expression levels of LSD1 were also increased in treated HMEC compared with control HMEC. Our data suggest that the induction of a single enzyme, LSD1, represents an early response to carcinogen exposure, which leads to the demethylation of histone H3 (Lys 4), which, in turn, may influence the expression of multiple genes critical in early-stage mammary carcinogenesis.
Bradley
Chastity
C
Department of Pathology, Vanderbilt University Medical Center, 4918 TVC, 22nd Avenue South Pierce, Nashville, TN 37232, USA.
van der Meer
Riet
R
Roodi
Nady
N
Yan
Heping
H
Chandrasekharan
Mahesh B
MB
Sun
Zu-Wen
ZW
Mernaugh
Ray L
RL
Parl
Fritz F
FF
D000611:Aminobiphenyl Compounds / Q000633:toxicity; D001564:Benzo(a)pyrene / Q000633:toxicity; D019921:Biotinylation; D001940:Breast / Q000166:cytology* / Q000502:physiology*; D002273:Carcinogens / Q000633:toxicity*; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006657:Histones / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism*; D006801:Humans; D007093:Imidazoles / Q000633:toxicity; D007135:Immunoglobulin Variable Region / Q000276:immunology; D019151:Peptide Library; D000072317:Polychlorinated Dibenzodioxins / Q000633:toxicity; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
D000611:Aminobiphenyl Compounds; D002273:Carcinogens; D006657:Histones; D007093:Imidazoles; D007135:Immunoglobulin Variable Region; D019151:Peptide Library; D000072317:Polychlorinated Dibenzodioxins; C006757:4-biphenylamine; D001564:Benzo(a)pyrene; C049584:2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine